Alexander J Mentzer
Biographic Data
| ID | 10707609 |
|---|---|
| NAME | Alexander J Mentzer |
| GIVEN NAMES | Alexander J |
| FAMILY NAME | Mentzer |
| SIGNATURE | MENTZER A J |
| AFFILIATIONS | Centre for Human Genetics |
| ORCID | 0000-0002-4502-2209 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2016 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Afri…
A genomic history of Aboriginal Australia
The population history of Aboriginal Australians remains largely uncharacterized. Here we generate high-coverage genomes for 83 Aboriginal Australians (speakers of Pama–Nyungan languages) and 25 Papuans from the New Guinea Highlands. We find that Papuan and Aboriginal Australian ancestors diversified 25–40 thousand years ago (kya), suggesting pre-Holocene population structure in the ancient continent of Sahul (Australia, New Guinea and Tasmania).…
No prominent works on this page.
A genomic history of Aboriginal Australia
The population history of Aboriginal Australians remains largely uncharacterized. Here we generate high-coverage genomes for 83 Aboriginal Australians (speakers of Pama–Nyungan languages) and 25 Papuans from the New Guinea Highlands. We find that Papuan and Aboriginal Australian ancestors diversified 25–40 thousand years ago (kya), suggesting pre-Holocene population structure in the ancient continent of Sahul (Australia, New Guinea and Tasmania).…
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Afri…
Geography (2 works) · 2019-20 coronavirus outbreak (1 works) · Archaeology (1 works) · Betacoronavirus (1 works) · Biological dispersal (1 works) · Biology (1 works) · Clinical trial (1 works) · Coronavirus (1 works) · Coronavirus disease 2019 (COVID-19) (1 works) · Coronavirus Infections (1 works)